Medifast Inc. (0K05)
LSE
12.24
+0.19 (+1.58%)
Closed
Aug 26, 2026
Day's Range
12.0012.29
52 wk Range
9.2714.65
Financial Statements - 0K05 - Medifast Inc.
Revenue
15.52B▲ 1.8%
Net Income
2.67B▼ 17.4%Net Margin 17.3%
EBITDA
5.77B▼ 8.3%
Free Cash Flow
5.10B▲ 274.4%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 15.52B | 15.26B | 14.24B | 9.13B |
| Cost of Goods | 3.48B | 3.22B | 3.33B | 2.41B |
| Gross Profit | 12.04B | 12.03B | 10.91B | 6.72B |
 Operating Expense | - | - | - | - |
| Operating Income | 3.78B | 4.46B | 4.49B | 3.12B |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 3.29B | 4.21B | 4.24B | 3.08B |
| Income Tax | 616M | 972M | 942M | 663.94M |
| Net Income | 2.67B | 3.24B | 3.30B | 2.41B |
| EPS Basic | 9.08 | 11.01 | 11.29 | 8.97 |
| EPS Diluted | 9.03 | 10.9 | 11.22 | 8.93 |
| Basic Shares Outstanding | 295.05M | 294.65M | 292.64M | 269.52M |
| Diluted Shares Outstanding | 295.05M | 294.65M | 292.64M | 269.52M |
| Ebit | - | - | - | - |
| Ebitda | 5.77B | 6.29B | 6.04B | 3.62B |
| Net Income Continuous Operations | 3.29B | 3.24B | 3.30B | 2.41B |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
